Intuitive Surgical, Inc. (ISRG) Experiences Notable Market Decline
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) concluded at $534.65, reflecting a decrease of -1.79%. This decline outpaced the S&P 500's daily loss of 0.79%. The Dow Jones Industrial Average fell by 0.94%, while the tech-heavy Nasdaq Composite lost 0.92%.
Performance Overview
As of today, Intuitive Surgical's shares have dipped 2.26% over the past month, underperforming the Medical sector, which saw a gain of 1.49%, and the S&P 500, which increased by 5.22%.
Earnings Forecast
Anticipation is building around Intuitive Surgical's upcoming earnings report, where analysts estimate an earnings per share (EPS) of $1.92. This would represent a growth of 7.87% compared to the same quarter last year. The consensus estimate for quarterly revenue stands at $2.35 billion, marking a 16.81% increase from the previous year.
Full-Year Projections
For the entire year, the Zacks Consensus Estimates project earnings of $7.84 per share and revenue of $9.65 billion, suggesting increases of +6.81% and +15.56%, respectively, year-over-year.
Analyst Revisions and Zacks Rank
Investors should keep an eye on any recent changes in analyst estimates for Intuitive Surgical, Inc. These revisions can indicate the evolving business landscape and overall analyst sentiment. Upward revisions typically reflect positivity regarding the company's operational capabilities.
According to our research, such estimate changes correlate strongly with stock price movements. To navigate this, we utilize the Zacks Rank, a unique model that incorporates these revisions to provide an operational rating system. The Zacks Rank ranges from #1 (Strong Buy) to #5 (Strong Sell) and boasts a strong track record, with #1 rated stocks returning an average of +25% annually since 1988. Currently, Intuitive Surgical holds a Zacks Rank of #2 (Buy), with the EPS estimate rising by 0.02% over the past month.
Valuation Metrics
In terms of valuation, Intuitive Surgical trades at a Forward P/E ratio of 69.44, which is a significant premium compared to its industry's Forward P/E of 25.22. Additionally, ISRG's PEG ratio stands at 4.59, which takes into account the expected earnings growth rate, contrasting with the Medical - Instruments industry average PEG of 2.26.
Industry Context
The Medical - Instruments industry is part of the broader Medical sector, currently holding a Zacks Industry Rank of 179, placing it in the bottom 28% of over 250 industries. The strength of these industry groups is assessed through the Zacks Industry Rank, based on the average Zacks Rank of individual stocks.
For those following ISRG's performance, visit Inside Ticker to stay updated.